PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2002 | 1 |
| 2003 | 38 |
| 2004 | 49 |
| 2005 | 15 |
| 2006 | 22 |
| 2007 | 12 |
| 2008 | 20 |
| 2009 | 19 |
| 2010 | 24 |
| 2011 | 28 |
| 2012 | 27 |
| 2013 | 59 |
| 2014 | 69 |
| 2015 | 86 |
| 2016 | 67 |
| 2017 | 85 |
| 2018 | 84 |
| 2019 | 86 |
| 2020 | 392 |
| 2021 | 316 |
| 2022 | 289 |
| 2023 | 125 |
| 2024 | 54 |
| 2025 | 47 |
| 2026 | 23 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Lancet Infect Dis"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial.
- Dawson R, Diacon AH, Variava E, Moloantoa T, Brumskine W, Ngwanto T, Zuma-Gwala N, Osman A, Rassool M, Bennet JA, Liu Y, Xu R, Li W, Takuva S, Hafkin J.
- Lancet Infect Dis. 2026 May 29;26(10):1010-1021. doi: 10.1016/S1473-3099(26)00143-X.
- PMCID: PMC13601027
Dawson R, et al.Lancet Infect Dis. 2026.PMCID: PMC13601027 -
Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study.
- Zhang B, Wu Q, Jhaveri R, Zhou T, Becich MJ, Bisyuk Y, Blanceró F, Chrischilles EA, Chuang CH, Cowell LG, Fort D, Horowitz CR, Kim S, Ladino N, Liebovitz DM, Liu M, Mosa ASM, Schwenk HT, Suresh S, Taylor BW, Williams DA, Morris JS, Forrest CB, Chen Y; RECOVER Consortium.
- Lancet Infect Dis. Author manuscript. 2025 Sep 30;26(2):127-138. doi: 10.1016/S1473-3099(25)00476-1.
- PMCID: PMC12671941
Zhang B, et al.Lancet Infect Dis. Author manuscript. 2025.PMCID: PMC12671941 -
Intention-to-diagnose and distinct research foci in diagnostic accuracy studies.
- Evans SR, Pennello G, Zhang S, Li Y, Wang Y, Cao Q, Komarow L, Hamasaki T, Petrides V, Meier K, Galicia NP, Fowler VG Jr, Boucher HW, Doernberg SB, Banerjee R, Rigatto MH, Kreiswirth BN, Bonomo RA, Chambers HF, Patel R.
- Lancet Infect Dis. Author manuscript. 2025 Mar 27;25(8):e472-e481. doi: 10.1016/S1473-3099(25)00070-2.
- PMCID: PMC13592427
Evans SR, et al.Lancet Infect Dis. Author manuscript. 2025.PMCID: PMC13592427 -
Re-visiting humoral constitutive antibacterial heterogeneity in bloodstream infections.
- Abe R, Ram-Mohan N, Yang S.
- Lancet Infect Dis. Author manuscript. 2023 Nov 6;24(4):e245-e251. doi: 10.1016/S1473-3099(23)00494-2.
- PMCID: PMC13591938
Abe R, et al.Lancet Infect Dis. Author manuscript. 2023.PMCID: PMC13591938 -
Correction to Lancet Infect Dis 2020; 20: 37-59.
- [No authors listed]
- Lancet Infect Dis. 2026 Jul 6;26(9):e335. doi: 10.1016/S1473-3099(26)00375-0.
- PMCID: PMC13490292
[No authors listed]Lancet Infect Dis. 2026.PMCID: PMC13490292 -
Correction to Lancet Infect Dis 2020; 20: 60-79.
- [No authors listed]
- Lancet Infect Dis. 2026 Jul 6;26(9):e335. doi: 10.1016/S1473-3099(26)00376-2.
- PMCID: PMC13490298
[No authors listed]Lancet Infect Dis. 2026.PMCID: PMC13490298 -
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.
- Cossa M, Ndege R, Meggi B, Mangu C, Leukes V, Sabi I, Khosa C, Kivuma B, Nguenha D, Riess F, Fernández-Escobar C, de la Torre-Perez L, Manjate P, Weisser M, Machiana A, Zachariah C, Tagliani E, Ehrlich J, Buech J, Schacht C, Sanz S, Singh S, Mnzava D, Schumacher SG, Cox H, Scott L, Ntinginya N, Kranzer K, Ruhwald M, Penn-Nicholson A, Garcia-Basteiro AL; TB-CAPT Consortium.
- Lancet Infect Dis. 2026 May 6;26(9):881-893. doi: 10.1016/S1473-3099(26)00133-7.
- PMCID: PMC13490300
Cossa M, et al.Lancet Infect Dis. 2026.PMCID: PMC13490300 -
Heteroresistance to cefepime-taniborbactam in metallo-β-lactamase-encoding Enterobacterales.
- Abbott C, Satola SW, Weiss DS.
- Lancet Infect Dis. Author manuscript. 2023 Jul 5;23(8):e277-e278. doi: 10.1016/S1473-3099(23)00426-7.
- PMCID: PMC13524416
Abbott C, et al.Lancet Infect Dis. Author manuscript. 2023.PMCID: PMC13524416 -
Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USA.
- Ulloa ER, Jaffurs D, Tran MT, Lin C, Tran H, Chan D, Nael A, Nigwekar SU, Nikolich MP, Tyne DV.
- Lancet Infect Dis. Author manuscript. 2026 Jun 9;26(10):e433-e443. doi: 10.1016/S1473-3099(26)00176-3.
- PMCID: PMC13459741
Ulloa ER, et al.Lancet Infect Dis. Author manuscript. 2026.PMCID: PMC13459741 -
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial.
- Ritchie AJ, Hassan O, Urasa N, Apanga PA, Kimathi R, Kalinga WF, Mtaka IM, Lyimo RG, Shabani MM, Orliacq F, Berg A, Xiang Z, Ahmed S, Athuman T, Ertl HCJ, Olotu A, Douglas AD; RAB002 study team.
- Lancet Infect Dis. 2026 Apr 28;26(8):843-857. doi: 10.1016/S1473-3099(26)00071-X.
- PMCID: PMC13391811
Ritchie AJ, et al.Lancet Infect Dis. 2026.PMCID: PMC13391811